BIOCORP Signs Exclusive Deal With VITROBIO PHARMA to Produce the First Drug Treatment Against Allergy Related to Pollution
(WorldNews France)

BIOCORP Signs Exclusive Deal With VITROBIO PHARMA to Produce the First Drug Treatment Against Allergy Related to Pollution 15 Nov 2019 07:30 CET Company Name BIOCORP ISN FR0012788065 Market Euronext Growth Symbol ALCOR The exclusive agreement between the two companies is for a period of 10 years Estimated turnover: more than EUR10 million over 10 years BIOCORP invests 600 KEUR in a new fully automated production line dedicated to this new health device Regulatory News: BIOCORP (FR0012788065 - ALCOR / Eligible PEA PME), a French company specializing in the development and manufacturing of medical devices and smart drug delivery systems, announces today the signature of an exclusive contract with...